The purpose of this research study is to test the study drug, referred to as remternetug, to determine its effectiveness for the study treatment of asymptomati…

Alzheimers DiseaseDementiaAlzheimers Disease, Familial

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT06647498

Phase 2

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease

The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's d…

Alzheimers DiseaseDementiaAlzheimers Disease, Familial

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT05552157